Novo Nordisk: Why Novo Nordisk Stock Dipped on Thursday
Novo Nordisk's (NYSE: NVO) is famous and celebrated for its cutting-edge obesity medication. But on Thursday, its stock felt like the company ingested some of its own treatment. Its U.S.-traded American depositary receipts (ADRs) saw their price slump by more than 2% following th
Read full article »
Novo Nordisk is a Denmark-based multinational pharmaceutical company that develops and commercializes diabetes care medications and devices for the healthcare industry.
Read more